Comparative Study Between Intravenous Clonidine and Preservative Free Intravenous Lignocaine in Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation

ABSTRACT

Objectives: To compare the attenuation of pressor responses by intravenous clonidine and preservative-free lignocaine to laryngoscopy and endotracheal intubation. Materials and Methods: A randomized, prospective, comparative, double-blinded study was conducted in 80 adult patients who were randomized into two groups of 40 each, group clonidine (Group C) and group lignocaine (Group L). Group C patients were given 2 µg/kg clonidine in 20 ml of normal saline as a slow infusion over 10 min prior to intubation. Group L patients were given 1.5 mg/kg of preservative-free 2% lignocaine in 20 ml of normal saline as a single-dose infusion over 3 min prior to intubation. Baseline vital and hemodynamic parameters were monitored during the perioperative period at 1-, 5-, and 10-min post-intubation. Results: The attenuation of heart rate (HR) after intubation was much better with clonidine than lignocaine as there is statistically significant difference in the mean HR between the two groups at 1, 5, and 10 min after intubation with the HR significantly lesser in the Group C than the Group L at all times after intubation. Both clonidine and lignocaine were effective in attenuating systolic blood pressure response after intubation, but clonidine was more effective than lignocaine as systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) in the Group C remained much lower than the Group L and the difference between the two groups was statistically significant at all times after intubation. Conclusion: Premedicating with a single slow infusion of 2 µg/kg i.v. clonidine has been proven to be effective in maintaining perioperative hemodynamic stability at 1, 5, and 10 min post-intubation than lignocaine.

KEYWORDS

• Laryngoscopy
• Intubation
• Pressor response
• Clonidine
• Lignocaine

Showing references and in-text citations exactly as published.

• DOI10.1177/0976500X221148539Copy

RELATED ARTICLES

Matched on section and article type within this issue of JPP.

• Article · VOLUME 13, ISSUE 4Australia’s Pharmacology Research: A Scientometric Assessment of High-Cited Papers During 2002–2021K.K. Mueen Ahmed, B.M. Gupta, Ghouse Modin Mamdapur · pp. 349–363Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Neuroprotective Effects of P-Coumaric Acid on Haloperidol-Induced Catalepsy Through Ameliorating Oxidative Stress and Brain Dopamine LevelAfsar S. Pathan, Pankaj G. Jain, Vivek S. Kumawat, Ujwal N. Katolkar, Sanjay J. Surana · pp. 364–374Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Antimicrobial Resistance, Phenotypic Characteristics, and Biofilm Production in Citrobacter freundii Isolates Obtained from Urinary Tract InfectionsPottathil Shinu · pp. 375–381Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Patterns of Medication Use and Their Determinants in Pregnancy among Women Admitted to the Obstetrics Wards of a Tertiary Care Hospital: A Cross-Sectional Study: Patterns of Medication Use and Their Determinants in PregnancyBoney Rajan, Elaina Pasangha, Padmini Devi, Shirley George · pp. 388–395Research ArticleSame type: Article